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We describe a man with a febrile illness and an eschar
that developed at the site of a tick bite. Rickettsia parkeri
was detected and isolated from the eschar. This report rep-
resents the second documented case of R. parkeri rick-
ettsiosis in a US serviceman in eastern Virginia.
I
n the United States, 4 species of spotted fever group
(SFG) rickettsiae are recognized as pathogens of
humans. These include Rickettsia rickettsii, the cause of
Rocky Mountain spotted fever (RMSF); R. felis, the cause
of fleaborne spotted fever; R. akari, the agent of rick-
ettsialpox; and R. parkeri (1,2). Of these, R. rickettsii is the
only pathogen definitely associated with tick bites. 
In 2004, Paddock et al. described the first recognized
case of infection in a patient with R. parkeri (1). That
patient, a US serviceman living in the Tidewater region of
eastern Virginia, had a mild febrile illness and multiple
eschars. He reported frequent tick and flea exposures but
could not recall a specific arthropod bite in the month
before illness. However, R. parkeri, a tick-associated rick-
ettsia (3), was subsequently isolated in cell culture from 1
eschar. (1) We present the second known case of spotted
fever due to R. parkeri in a serviceman (the third case
overall) and its unequivocal association with tick bite.
The Case
A 53-year-old US serviceman was seen at our clinic
on September 8, 2006; he reported a 2-day history of fever,
malaise, and rash. He denied headache, nausea, vomiting,
or myalgia. He had recently returned from a vacation in the
Virginia Beach area, where he had removed a large brown
tick with white markings from his right pretibial region.
The patient estimated that the tick had been attached ≈8
hours before being removed. Four days after the tick was
removed, an eschar developed at the bite site. Three days
later, temperatures up to 39°C and drenching night sweats
that persisted for 2 days developed. He then sought care.
On examination, his temperature was 38°C. A non-
tender, nonpruritic eschar that measured 1 cm × 1 cm was
visible on his right lower extremity (Figure 1) along with
≈15 nontender, nonpruritic papules on his torso, upper
arms, and legs (Figure 2). The remainder of his physical
examination was normal. Laboratory studies were normal
except for a leukocyte count of 3.4 × 109 cells/L (normal
4–11 × 109 cells/L) and an aspartate aminotransferase level
of 38 U/L (normal 8–33 U/L).
The patient was admitted to the hospital and treated
with oral doxycycline 100 mg twice a day. Fevers and
malaise immediately resolved after the first dose. The
patient was discharged, and the rash resolved after 3–4
days of therapy.
DNA extracted from skin-biopsy specimens of the
proximal tibial eschar and  a shoulder papule was positive
by 2 real-time PCR assays designed to amplify segments
of the 17-kDa antigen and outer membrane protein B genes
of all Rickettsia spp. and tickborne SFG rickettsiae, respec-
tively (4,5). Amplicons obtained from 2 additional genes,
gltA (333 bp) and sca4 (849 bp), were sequenced and
determined to be 100% identical to those of R. parkeri
(GenInfo Identifier nos. 1389996; 13568656). The
histopathology of the shoulder papule showed mild super-
ficial perivascular inflammation without eosinophils.
Acute-phase serum and whole blood samples from the
patient were also tested by real-time PCR and were nega-
tive. R. parkeri (Ft. Story strain) was isolated in Vero E6
cells from a portion of the eschar biopsy specimen.
Immunohistochemical staining of the shoulder papule
identified occasional spotted fever rickettsiae in the
inflammatory cell infiltrate. Acute- and convalescent-
phase serum specimens were tested for immunoglobulin G
antibodies reactive with SFG and typhus group (TG) rick-
ettsiae by using ELISAs with R. rickettsii and R. typhi anti-
gens. The titers for the SFG ELISA acute- and
convalescent-phase serum samples were <100 and 1,600,
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Georgia, USA Figure 1. Eschar on right pretibial region (arrow).respectively. Both samples were negative (titer <100) for
the TG ELISA.
Conclusions
R. parkeri was first isolated in 1937 from
Amyblyomma maculatum ticks found on cattle in the Gulf
Coast region of Texas (3), but its role as a human pathogen
was unknown. For many years investigators speculated
that agents other than R. rickettsii, including R. parkeri,
caused mild RMSF-like illnesses in the United States (6,7).
However, the role of R. parkeri as a pathogen of humans
was not confirmed until 2002, when R. parkeri was isolat-
ed from a patient with a relatively mild febrile illness and
multiple eschars (1). Confirmed cases of R. parkeri rick-
ettsiosis have been described only twice (1,8), and the
prevalence of this disease is unknown; however, many
cases of this infection have likely been misidentified as
RMSF (6). Recently, Raoult and Paddock analyzed serum
specimens of 15 US patients who had an earlier diagnosis
of RMSF and identified 4 that reacted with a 120-kDa pro-
tein of R. parkeri, a finding suggestive of infection with
this agent (9). This hypothesis is further supported by sero-
prevalence studies of US military personnel that showed
that 10% of those tested were positive for SFG rickettsiae
when a R. rickettsii ELISAantigen was used (10). Because
of recognized cross-reactivity of R. rickettsii with antigens
of other SFG rickettsiae, including R. parkeri, this level of
serologic reactivity could represent mild, self-limited
infections with other SFG rickettsiae, including R. parkeri,
that are less virulent than R. rickettsii.
Our patient had a single eschar at the site of tick
attachment. Although it has been presumed that ticks are
involved in the transmission of this disease, this is the first
clear documentation of this occurrence. The infection can
apparently be transmitted within several hours of attach-
ment because the patient was certain of the maximum
interval that the tick could have been attached to a visible
region of his leg. Finally, the general description of the tick
matches that of A. maculatum, the putative vector of R.
parkeri rickettsiosis, and this tick has been collected previ-
ously in southeastern Virginia (11).
R. parkeri is the newest member of the SFG rickettsi-
ae in the Western Hemisphere to be conclusively associat-
ed with illness in humans (12). Because 2 of the 3 patients
described to date were US servicemen in the Virginia
Tidewater region, where thousands of military personnel
are stationed, this tickborne infection has potential military
relevance. Serologic tests specifically for R. parkeri are
not widely available, and an accurate diagnosis is best
made by using PCR testing of a biopsy specimen of
eschars or papules. Adefinitive diagnosis can also be made
by using cell culture isolation techniques with the same
biopsy specimen, as described for other eschar-associated
rickettsioses (12).
Clinicians should be aware of this newly noted rick-
ettsial illness, specifically in the eastern coastal region of
the United States. They should consider this diagnosis for
patients with mild rickettsiosis-like illness and single or
multiple eschars.
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